Dr. Horacio Pablo Groisman, MD

Dr. Groisman practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. Groisman's NPI, 1598765240, was assigned on July 22, 2005. Dr. Groisman graduated from University of Buenos Aires in 1976. Dr. Groisman holds Florida license ME44702.

Dr. Groisman's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016. The practice phone is (305) 558-3724.

Dr. Groisman's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. The medical group on file is South Florida ENT Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Groisman practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Groisman's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Groisman is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Groisman's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists acute sinusitis, chronic nasal allergies, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Groisman treats.

CMS data shows 3,557 Medicare services from Dr. Groisman across 20 procedure codes in 2024, for 525 Medicare patients. Medicare paid $142,634 for them. Every service was in an office.

CMS counts 525 Medicare patients who saw Dr. Groisman in 2024. The largest group is 75 to 84, with 211 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Groisman's median patient age at 70, with 57% women.

In 2024, Dr. Groisman wrote 2,224 Medicare Part D claims for 825 patients. 98% of them were for generic drugs. CMS names the drug for 2,137 of them, across 19 drugs with 11 or more claims each, at $49,892 in total drug cost. In 2023, CMS named 2,601 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Groisman for performance year 2024, reported individually. Dr. Groisman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 39 general payments to Dr. Groisman from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $399.

Dmand AI lists 6 awards for Dr. Groisman, most recently CMS Stage 1 EHR in 2013.

Dr. Groisman graduated from University of Buenos Aires in 1976. Dr. Groisman is a member of NHS.

Dr. Groisman is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.